Search results
Is Sanofi SA (NASDAQ:SNY) the Best International Pharmaceutical Dividend Stock?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since Sanofi SA...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 21 hours agoNovavax has become a safer buy of late COVID-19 vaccine maker...shares if they think a development may lead to better financial results. For a stock...
Sanofi (NASDAQ:SNY) Shares Acquired by Putnam Investments LLC
ETF DAILY NEWS· 3 days agoPutnam Investments LLC boosted its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 25.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,342,709 ...
Regeneron CEO Leonard Schleifer sells over $25 million in company stock By Investing.com
Investing.com· 1 day agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) has reported a series of transactions by...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks· 1 day agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop FG-M701, a next-generation TL1A antibody, for IBD indications.
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Investor's Business Daily· 2 days agoSanofi, which records sales of Dupixent, reported $11.6 billion in sales last year. This year, sales...
Exploring Three Top Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance· 2 days agoIn recent trading sessions, the French stock market has shown resilience, with the CAC 40 Index...
Charles River (CRL) Partners to Reduce Animal Research Usage
Zacks via Yahoo Finance· 4 days agoPrice Performance Over the past year, Charles River shares have risen 4.4% compared with the...
Questor: Investors are undervaluing this London company’s pubs and hotels
The Telegraph via Yahoo Finance· 4 days agoWe are hopefully not tempting providence by taking a fresh look at Fuller Smith & Turner ahead of...
Health Care Roundup: Market Talk
The Wall Street Journal· 3 days agoThe French pharmaceutical company anticipates peak sales of over EUR500 million for its drug marketed as Iqirvo... think Iqirvo’s approval should be...
